Nexeon MedSystems

Nexeon (OTCQB: $NXNN) is a medical device company developing innovative neurostimulation products for treatment of debilitating #neurological diseases.

[Nexeon MedSystems @NexeonMed]

#ParkinsonsDisease is known as a #MovementDisorder as the symptoms cause problems with movement. The most common symptoms include bradykinesia, tremor, and rigidity. @ParkinsonDotOrg provides information on additional symptoms: https://t.co/HkYnWfniVu

[Nexeon MedSystems @NexeonMed]

#ParkinsonsDisease is a neurodegenerative disorder that affects predominantly dopamine-producing neurons in a specific area of the brain called substantia nigra. Learn the symptoms from @ParkinsonDotOrg: https://t.co/UqvmQ3Mcb5

[Nexeon MedSystems @NexeonMed]

Nexeon CEO Will Rosellini discusses our initial product, the Synapse™ #DeepBrainStimulation System, being developed for certain #MovementDisorders associated with #ParkinsonsDisease in our corporate video. Watch here: https://t.co/5YqJhReFuH $NXNN

[Nexeon MedSystems @NexeonMed]

Deep brain stimulation is used to treat a number of neurological conditions including #EssentialTremor, #ParkinsonsDisease, and #ChronicPain https://t.co/MBOqZrc02e @MayoClinic

[Nexeon MedSystems @NexeonMed]

Listen to our CEO explain Nexeon's development of closed-loop #neurostimulation products that are designed to improve the quality-of-life of patients suffering from debilitating #neurological diseases: https://t.co/5YqJhReFuH $NXNN

[Nexeon MedSystems @NexeonMed]

Deep brain stimulation involves implanting electrodes within certain areas of your brain. These electrodes produce electrical impulses that regulate abnormal impulses. Learn more via @MayoClinic: https://t.co/MBOqZrc02e

[Nexeon MedSystems @NexeonMed]

$NXNN CEO comments on the potential of #neurostimulation for the treatment of symptoms associated with #opioid withdrawal & the Company's Zero Point™ Stimulation System https://t.co/J168BXvwrc

[Nexeon MedSystems @NexeonMed]

Through the Innovation Challenge, Nexeon is requesting the FDA’s early involvement in the regulatory plan with the goal of making Zero Point available over-the-counter to treat #opioid withdrawal https://t.co/J168BXvwrc $NXNN

[Nexeon MedSystems @NexeonMed]

$NXNN is developing the Zero Point™ Stimulation System, a non-invasive neurostimulation device designed to provide low-levels of electrical stimulation to activate nerves for the treatment of a number of diseases & disorders, including #opioid withdrawal https://t.co/J168BXvwrc

[Nexeon MedSystems @NexeonMed]

Nexeon Announces Submission for FDA Innovation Challenge https://t.co/L1IXR5ZMmq $NXNN

[Nexeon MedSystems @NexeonMed]

$NXNN to collaborate with Neurotargeting LLC to develop an intuitive, image-guided software tool for 2D/3D mapping of disease-related neural signals over patient & device data for more efficient and effective programming of newer, more complex #DBS systems https://t.co/zXH8cesvFZ

[Nexeon MedSystems @NexeonMed]

.@NINDSnews intends to fund $1.5 million over 3 years to support the development of novel cloud-based software to improve programming for deep #brain stimulation https://t.co/zXH8cesvFZ $NXNN

[Nexeon MedSystems @NexeonMed]

.@NINDSnews grant, received through our wholly-owned subsidiary Nexeon MedSystems Puerto Rico Operations Company Corporation, will support the development of novel cloud-based software to improve programming for #DeepBrainStimulation https://t.co/zXH8cesvFZ $NXNN

[Nexeon MedSystems @NexeonMed]

Nexeon announced that it has received an $830,000 grant from @NINDSnews of @NIH https://t.co/ayoKhGLZir $NXNN

[Nexeon MedSystems @NexeonMed]

Our new corporate video is now live. Visit our YouTube channel for more. https://t.co/MtexOWd0FQ

[Nexeon MedSystems @NexeonMed]

Check out our latest corporate presentation: https://t.co/bnfCsddDXY

[Nexeon MedSystems @NexeonMed]

Mind control? Thanks to neurotech, it's not unfeasible. “Brains are free & can be monitored everywhere, thanks to new portable, affordable & reliable neurotech that allows everyone to access some of their brain activity on their phones” https://t.co/IDkAIAjpNC

[Nexeon MedSystems @NexeonMed]

"app of control theory to the study of the brain physiology has led to dev of computer tools, intelligent neurostimulators that can adapt the stim to the patient’s conditions in real-time, & deliver only minimal amounts of electrical stim as needed.” https://t.co/tevdLUpXX5

[Nexeon MedSystems @NexeonMed]

“At the end of the program, teams will perform a DoD-relevant demo of their choosing in a human... the final demo could include a subject controlling multiple drones in a VR setup, while receiving sensory feedback to portray the status of each drone.” https://t.co/kLSskWO0XA

[Nexeon MedSystems @NexeonMed]

DARPA launches Nonsurgical Neural Interface project - Homeland Preparedness News https://t.co/g9Cg6cRP9K